Clik here to view.
BeiGene Clinical Data Presentations at 2022 ASCO Annual Meeting Demonstrate...
CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and...
View ArticleClik here to view.
MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation...
SAN DIEGO & TOKYO MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global...
View ArticleClik here to view.
Lumenis OptiLight荣获2022年MedTech Breakthrough奖：眼科最佳新技术解决方案
以色列约克尼穆 (美国商业资讯)–领先的能量型美容和眼科医疗设备公司Lumenis Be.今天宣布，OptiLight荣获竞争激烈的MedTech...
View ArticleClik here to view.
卡妥索单抗治疗晚期胃癌伴腹膜转移临床研究成果入选2022ASCO年会
中国广州 (美国商业资讯)–凌腾医药，一家专注于T细胞衔接抗体开发的临床阶段生物制药公司，今日宣布，美国临床肿瘤学会（American Society of Clinical Oncology, ASCO）已接收卡妥索单抗治疗晚期胃癌伴腹膜转移的Ⅲ期临床试验第一阶段研究成果作为摘要发布。 摘要编号：e16102 摘要标题：Global multi-center phase I trial of...
View ArticleClik here to view.
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with...
GUANGZHOU, China LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that...
View ArticleClik here to view.
IntelliCentrics的创新技术帮助Advanced Dallas Hospital ＆ Clinics推进提供前沿医学和个性化患者护理的使命
达拉斯 (美国商业资讯)–SEC³URE Ethos、SEC³URE Passport、Link & GO!、BioBytes™和BioBytes™ Visitor的创新缔造者中智全球(IntelliCentrics, 6819.HK) 今天宣布，Advanced Dallas Hospital & Clinics已加入中智全球以信任为基础的超大型医疗保健社区SEC³URE...
View ArticleClik here to view.
ルミナスのOptiLightが2022年メドテック・ブレークスルー賞の「最優秀眼科用新技術ソリューション」部門を受賞
イスラエル・ヨクネアムイリト （ビジネスワイヤ） —...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Pemetrexed for Injection...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today...
View ArticleClik here to view.
Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian...
OTTAWA, Ontario Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human...
View ArticleClik here to view.
Taiwan Excellence’s “Explore Every Terrain” Pavilion Showcases Trailblazing...
DENVER, Colorado, Outdoor Retailer Summer Show – With the theme “Explore Every Terrain,” the Taiwan External Trade Development Council (TAITRA), Taiwan’s foremost trade promotion organization, is...
View ArticleClik here to view.
MindMaze and The University of Auckland Partner on Novel Early Intervention...
BALTIMORE & LAUSANNE, Switzerland & AUCKLAND, New Zealand MindMaze, a category-defining global leader in digital therapeutics (DTx) for neurological recovery and care, in partnership with...
View ArticleClik here to view.
CANbridge Pharmaceuticals to Present at the Jefferies Global Healthcare...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of...
View ArticleClik here to view.
BGI Releases 1st Panoramic Atlases of Life
SHENZHEN, China International scientists led by China’s BGI•Research released the world’s first panoramic spatial atlases of life on May 4, examining the cellular dynamics of organisms at different...
View ArticleClik here to view.
LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized...
TORONTO 12.7 million Americans aged 65 and older are projected to have Alzheimer’s dementia by 2050. LUCID and JT are now partnering on the development of a prescription digital therapeutic for...
View ArticleClik here to view.
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor...
ST. HELIER, Jersey & SHANGHAI, China & SAN FRANCISCO & CAMBRIDGE, Mass. Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms...
View ArticleClik here to view.
Patritumab Deruxtecan Continues to Show Promising Clinical Activity in...
TOKYO & MUNICH & BASKING RIDGE, N.J. New data from Daiichi Sankyo’s (TSE: 4568) patritumab deruxtecan (HER3-DXd) showed clinically meaningful and durable responses in two early-stage trials...
View ArticleClik here to view.
ENHERTU® Reduced the Risk of Disease Progression or Death by 50% vs....
TOKYO & MUNICH & BASKING RIDGE, N.J. Detailed positive results from the pivotal DESTINY-Breast04 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated superior and...
View ArticleClik here to view.
Latest Data of InnoCare’s Orelabrutinib for the Treatment of SLE Presented at...
BEIJING InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib for the...
View ArticleClik here to view.
Organon在公司成立一周年之际发布首份ESG报告，介绍其全球ESG战略和承诺
新泽西州泽西城 (美国商业资讯)–全球女性医疗保健公司Organon (NYSE: OGN)今天宣布发布其2021年环境、社会和治理(ESG)报告，这是该公司首次发布ESG报告。报告介绍了Organon的ESG平台“Her Promise”，并详细介绍了公司如何努力帮助妇女和女孩通过更高的健康水平来充分发挥她们的潜力，开创有希望的未来。ESG报告的发布和Her...
View ArticleClik here to view.